Marine Shipping
Build Your Comparison
Side-by-side financial analysisStock Comparison
CMBT vs MATX vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Marine Shipping
Banks - Diversified
CMBT vs MATX vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Marine Shipping | Marine Shipping | Banks - Diversified |
| Market Cap | $3.56B | $6.14B | $896.00B |
| Revenue (TTM) | $1.67B | $3.32B | $280.33B |
| Net Income (TTM) | $161M | $429M | $57.05B |
| Gross Margin | 35.5% | 18.4% | 60.0% |
| Operating Margin | 27.4% | 13.6% | 25.9% |
| Forward P/E | 7.7x | 14.4x | 14.4x |
| Total Debt | $5.57B | $727M | $942.38B |
| Cash & Equiv. | $147M | $142M | $343.34B |
CMBT vs MATX vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Cmb.Tech N.V. (CMBT) | 100 | 190.2 | +90.2% |
| Matson, Inc. (MATX) | 100 | 694.0 | +594.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CMBT vs MATX vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CMBT has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.
- Rev growth 77.2%, EPS growth -83.6%, 3Y rev CAGR 24.2%
- Lower volatility, beta 0.42, current ratio 0.52x
- 77.2% revenue growth vs MATX's -2.3%
MATX is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 5.4% 10Y total return vs JPM's 465.8%
- PEG 0.56 vs JPM's 0.81
- +77.5% vs JPM's +21.8%
JPM is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 15 yrs, beta 0.94, yield 1.9%
- Beta 0.94, yield 1.9%, current ratio 0.52x
- 20.4% margin vs CMBT's 9.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 77.2% revenue growth vs MATX's -2.3% | |
| Value | Lower P/E (7.7x vs 14.4x) | |
| Quality / Margins | 20.4% margin vs CMBT's 9.6% | |
| Stability / Safety | Beta 0.42 vs MATX's 1.30 | |
| Dividends | 1.9% yield, 15-year raise streak, vs CMBT's 0.6% | |
| Momentum (1Y) | +77.5% vs JPM's +21.8% | |
| Efficiency (ROA) | 9.3% ROA vs JPM's 1.3%, ROIC 10.8% vs 4.5% |
CMBT vs MATX vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CMBT vs MATX vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 168.3x CMBT's $1.7B. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CMBT's 9.6%. On growth, CMBT holds the edge at +160.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $1.7B | $3.3B | $280.3B |
| EBITDAEarnings before interest/tax | $856M | $644M | $81.4B |
| Net IncomeAfter-tax profit | $161M | $429M | $57.0B |
| Free Cash FlowCash after capex | -$612M | $418M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +35.5% | +18.4% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +27.4% | +13.6% | +25.9% |
| Net MarginNet income ÷ Revenue | +9.6% | +12.9% | +20.4% |
| FCF MarginFCF ÷ Revenue | -36.7% | +12.6% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +160.6% | -3.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -35.4% | -15.1% | +16.0% |
Valuation Metrics
MATX leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 14.6x trailing earnings, MATX trades at a 31% valuation discount to CMBT's 21.2x P/E. Adjusting for growth (PEG ratio), MATX offers better value at 0.57x vs JPM's 0.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $3.6B | $6.1B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $9.0B | $6.7B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 21.23x | 14.56x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.67x | 14.44x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.57x | 0.90x |
| EV / EBITDAEnterprise value multiple | 11.84x | 8.45x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 2.13x | 1.84x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.36x | 2.28x | 2.47x |
| Price / FCFMarket cap ÷ FCF | — | 39.97x | 8.88x |
Profitability & Efficiency
MATX leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $6 for CMBT. MATX carries lower financial leverage with a 0.26x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), MATX scores 5/9 vs CMBT's 4/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +6.2% | +15.9% | +15.9% |
| ROA (TTM)Return on assets | +1.9% | +9.3% | +1.3% |
| ROICReturn on invested capital | +4.7% | +10.8% | +4.5% |
| ROCEReturn on capital employed | +6.8% | +11.3% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 5 |
| Debt / EquityFinancial leverage | 2.12x | 0.26x | 2.60x |
| Net DebtTotal debt minus cash | $5.4B | $585M | $599.0B |
| Cash & Equiv.Liquid assets | $147M | $142M | $343.3B |
| Total DebtShort + long-term debt | $5.6B | $727M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 1.09x | 127.63x | 0.74x |
Total Returns (Dividends Reinvested)
MATX leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MATX five years ago would be worth $32,937 today (with dividends reinvested), compared to $21,820 for JPM. Over the past 12 months, MATX leads with a +77.5% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors MATX at 40.2% vs CMBT's 14.0% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +74.4% | +63.8% | -0.5% |
| 1-Year ReturnPast 12 months | +73.1% | +77.5% | +21.8% |
| 3-Year ReturnCumulative with dividends | +48.2% | +175.6% | +138.2% |
| 5-Year ReturnCumulative with dividends | +169.1% | +229.4% | +118.2% |
| 10-Year ReturnCumulative with dividends | +191.6% | +538.4% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +14.0% | +40.2% | +33.6% |
Risk & Volatility
Evenly matched — CMBT and MATX each lead in 1 of 2 comparable metrics.
Risk & Volatility
CMBT is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than MATX's 1.30 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MATX currently trades 99.4% from its 52-week high vs CMBT's 87.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.42x | 1.30x | 0.94x |
| 52-Week HighHighest price in past year | $17.72 | $203.08 | $337.25 |
| 52-Week LowLowest price in past year | $7.78 | $86.97 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +87.5% | +99.4% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 49.7 | 69.0 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 218K | 7.0M |
Analyst Outlook
JPM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CMBT as "Hold", MATX as "Buy", JPM as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -5.9% for MATX (target: $190). For income investors, JPM offers the higher dividend yield at 1.86% vs CMBT's 0.59%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $190.00 | $339.75 |
| # AnalystsCovering analysts | 3 | 11 | 61 |
| Dividend YieldAnnual dividend ÷ price | +0.6% | +0.7% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 13 | 15 |
| Dividend / ShareAnnual DPS | $0.09 | $1.44 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.9% | +3.9% |
MATX leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). JPM leads in 2 (Income & Cash Flow, Analyst Outlook). 1 tied.
CMBT vs MATX vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CMBT or MATX or JPM a better buy right now?
For growth investors, Cmb.
Tech N. V. (CMBT) is the stronger pick with 77. 2% revenue growth year-over-year, versus -2. 3% for Matson, Inc. (MATX). Matson, Inc. (MATX) offers the better valuation at 14. 6x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Matson, Inc. (MATX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CMBT or MATX or JPM?
On trailing P/E, Matson, Inc.
(MATX) is the cheapest at 14. 6x versus Cmb. Tech N. V. at 21. 2x. On forward P/E, Cmb. Tech N. V. is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Matson, Inc. wins at 0. 56x versus JPMorgan Chase & Co. 's 0. 81x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CMBT or MATX or JPM?
Over the past 5 years, Matson, Inc.
(MATX) delivered a total return of +229. 4%, compared to +118. 2% for JPMorgan Chase & Co. (JPM). Over 10 years, the gap is even starker: MATX returned +538. 4% versus CMBT's +191. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CMBT or MATX or JPM?
By beta (market sensitivity over 5 years), Cmb.
Tech N. V. (CMBT) is the lower-risk stock at 0. 42β versus Matson, Inc. 's 1. 30β — meaning MATX is approximately 208% more volatile than CMBT relative to the S&P 500. On balance sheet safety, Matson, Inc. (MATX) carries a lower debt/equity ratio of 26% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CMBT or MATX or JPM?
By revenue growth (latest reported year), Cmb.
Tech N. V. (CMBT) is pulling ahead at 77. 2% versus -2. 3% for Matson, Inc. (MATX). On earnings-per-share growth, the picture is similar: JPMorgan Chase & Co. grew EPS 1. 5% year-over-year, compared to -83. 6% for Cmb. Tech N. V.. Over a 3-year CAGR, CMBT leads at 24. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CMBT or MATX or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 9. 6% for Cmb. Tech N. V. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 14. 0% for MATX. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CMBT or MATX or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Matson, Inc. (MATX) is the more undervalued stock at a PEG of 0. 56x versus JPMorgan Chase & Co. 's 0. 81x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Cmb. Tech N. V. (CMBT) trades at 7. 7x forward P/E versus 14. 4x for Matson, Inc. — 6. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — CMBT or MATX or JPM?
All stocks in this comparison pay dividends.
JPMorgan Chase & Co. (JPM) offers the highest yield at 1. 9%, versus 0. 6% for Cmb. Tech N. V. (CMBT).
09Is CMBT or MATX or JPM better for a retirement portfolio?
For long-horizon retirement investors, Cmb.
Tech N. V. (CMBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 0. 6% yield, +191. 6% 10Y return). Both have compounded well over 10 years (CMBT: +191. 6%, MATX: +538. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CMBT and MATX and JPM?
These companies operate in different sectors (CMBT (Industrials) and MATX (Industrials) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CMBT is a small-cap high-growth stock; MATX is a small-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.